Protein-induced glomerular hyperfiltration: role of hormonal factors. 1988

G G Krishna, and G Newell, and E Miller, and P Heeger, and R Smith, and M Polansky, and S Kapoor, and R Hoeldtke
Department of Medicine, Temple University, Philadelphia, Pennsylvania.

High protein diets acutely elevate the glomerular filtration rate. To characterize this response we administered 1 g of protein/kg body weight as a beef steak meal to nine, healthy male subjects and measured glomerular filtration rate (inulin clearance), renal plasma flow (p-amino hippurate clearance), plasma renin activity, aldosterone and plasma and urinary catecholamines. The subjects ingested the meal on three separate days and were pretreated with either placebo, 50 mg indomethacin (to inhibit renal prostaglandin synthesis), or 10 mg enalapril (to inhibit angiotensin II synthesis). Following placebo treatment protein feeding significantly increased the glomerular filtration rate, from a pre-meal level of 101 +/- 7 ml/min/1.73 m2 to a post-meal level of 130 +/- 6 ml/min/1.73 m2, P less than 0.005. A parallel rise in renal plasma flow and a fall in renal vascular resistance were noted. Indomethacin pretreatment attenuated the increase in glomerular filtration rate following the protein meal, 105 +/- 6 ml/min/1.73 m2 pre-meal level to 118 +/- 4 ml/min/1.73 m2 post-meal, P greater than 0.1. Enalapril pretreatment had no significant effect on protein-induced glomerular hyperfiltration. Protein feeding following placebo increased plasma aldosterone concentration while the concentrations were unchanged in the studies where enalapril or indomethacin was administered. Protein feeding following placebo or indomethacin did not alter plasma renin activity while plasma renin activity rose following enalapril administration. Urinary norepinephrine excretion rose while plasma norepinephrine concentration was unchanged in all three study groups. A decrease in urinary dopamine excretion was also noted four hours after the protein meal was ingested.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D009318 Natriuresis Sodium excretion by URINATION. Natriureses
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D004044 Dietary Proteins Proteins obtained from foods. They are the main source of the ESSENTIAL AMINO ACIDS. Proteins, Dietary,Dietary Protein,Protein, Dietary
D004656 Enalapril An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE. Enalapril Maleate,MK-421,MK421,Renitec,Renitek,MK 421,Maleate, Enalapril

Related Publications

G G Krishna, and G Newell, and E Miller, and P Heeger, and R Smith, and M Polansky, and S Kapoor, and R Hoeldtke
June 1991, The American journal of physiology,
G G Krishna, and G Newell, and E Miller, and P Heeger, and R Smith, and M Polansky, and S Kapoor, and R Hoeldtke
April 1988, The American journal of physiology,
G G Krishna, and G Newell, and E Miller, and P Heeger, and R Smith, and M Polansky, and S Kapoor, and R Hoeldtke
July 2015, American journal of physiology. Renal physiology,
G G Krishna, and G Newell, and E Miller, and P Heeger, and R Smith, and M Polansky, and S Kapoor, and R Hoeldtke
January 1992, Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma,
G G Krishna, and G Newell, and E Miller, and P Heeger, and R Smith, and M Polansky, and S Kapoor, and R Hoeldtke
October 1987, The Western journal of medicine,
G G Krishna, and G Newell, and E Miller, and P Heeger, and R Smith, and M Polansky, and S Kapoor, and R Hoeldtke
December 1992, The Journal of pharmacology and experimental therapeutics,
G G Krishna, and G Newell, and E Miller, and P Heeger, and R Smith, and M Polansky, and S Kapoor, and R Hoeldtke
July 2022, Nature reviews. Nephrology,
G G Krishna, and G Newell, and E Miller, and P Heeger, and R Smith, and M Polansky, and S Kapoor, and R Hoeldtke
September 2010, Acta physiologica (Oxford, England),
G G Krishna, and G Newell, and E Miller, and P Heeger, and R Smith, and M Polansky, and S Kapoor, and R Hoeldtke
February 1995, Diabetes,
G G Krishna, and G Newell, and E Miller, and P Heeger, and R Smith, and M Polansky, and S Kapoor, and R Hoeldtke
January 1996, Journal of the American Society of Nephrology : JASN,
Copied contents to your clipboard!